American Financial Group Inc Biogen Inc. Transaction History

American Financial Group Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $906,500 - $1.45 Million	-3,500 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $850,325 - $996,205	-3,500 Reduced 50.0%	3,500 $979,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $1.97 Million - $2.31 Million	7,000	7,000 $2.19 Million

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on American Financial Group Inc with notifications on news.